Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial

The association of interleukin-2 (IL-2), interferon alpha-2a (IFNα), 5-fluorouracil (5-FU) has been reported to induce response in metastatic renal cell carcinoma (MRCC). This study evaluated IL-2, IFNα and 5FU as second-line treatment after failure under immunotherapy. A total of 35 patients receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravaud, A, Trufflandier, N, Ferrière, J M, Debled, M, Palussière, J, Cany, L, Gaston, R, Mathoulin-Pélissier, S, Bui, B N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395282/
https://www.ncbi.nlm.nih.gov/pubmed/14676797
http://dx.doi.org/10.1038/sj.bjc.6601419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395282/
https://www.ncbi.nlm.nih.gov/pubmed/14676797
http://dx.doi.org/10.1038/sj.bjc.6601419

Ejemplares similares